{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "314399", "DateCompleted": {"Year": "1979", "Month": "11", "Day": "21"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["ger"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0015-8178", "JournalIssue": {"Volume": "97", "Issue": "28", "PubDate": {"Year": "1979", "Month": "Jul", "Day": "26"}}, "Title": "Fortschritte der Medizin", "ISOAbbreviation": "Fortschr Med"}, "ArticleTitle": "[Enelbin rheumatism ointment in rheumatic diseases. Results of a double-blind study for the determination of efficacy].", "Pagination": {"StartPage": "1249", "EndPage": "1252", "MedlinePgn": "1249-52"}, "Abstract": {"AbstractText": ["Enelbin-Rheuma-ointment and a reference ointment were compared with regard to effectiveness in a double-blind trial in 100 patients with gonarthrosis, osteoarthrosis of the spine and humeroscapular periarthropathy. Both ointments showed good results regarding spontaneous pain, pain on pressure and motion, reduction of mobility, swelling and muscular tension. The success of treatment was statistically significantly better in the Enelbin-Rheuma-ointment treated patients."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Bach", "ForeName": "G L", "Initials": "GL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Fotiades", "ForeName": "P", "Initials": "P"}], "PublicationTypeList": ["Clinical Trial", "Controlled Clinical Trial", "Journal Article", "Randomized Controlled Trial"], "VernacularTitle": "Enelbin-Rheuma-Salbe bei Erkrankungen des rheumatischen Formenkreises. Ergebnisse einer Doppelblind-Studie zum Wirksamkeitsnachweis."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Fortschr Med", "NlmUniqueID": "2984763R", "ISSNLinking": "0015-8178"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Ethylene Glycols"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydroxybenzoates"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "0", "NameOfSubstance": "Ointments"}, {"RegistryNumber": "0", "NameOfSubstance": "Salicylates"}, {"RegistryNumber": "3J50XA376E", "NameOfSubstance": "Thymol"}, {"RegistryNumber": "77190-12-6", "NameOfSubstance": "Enelbin"}, {"RegistryNumber": "9005-49-6", "NameOfSubstance": "Heparin"}, {"RegistryNumber": "GM8Q3JM2Y8", "NameOfSubstance": "Vanillic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ethylene Glycols"}, {"QualifierName": [], "DescriptorName": "Eucalyptus"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Heparin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hydroxybenzoates"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": ["standards"], "DescriptorName": "Ointments"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Rheumatic Diseases"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Salicylates"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Thymol"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Vanillic Acid"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1979", "Month": "7", "Day": "26"}, {"Year": "1979", "Month": "7", "Day": "26", "Hour": "0", "Minute": "1"}, {"Year": "1979", "Month": "7", "Day": "26", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["314399"]}}]}